{"name":"NovaRx Corporation","slug":"novarx-corporation","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Lucanix™","genericName":"Lucanix™","slug":"lucanix","indication":"Melanoma (adjuvant setting)","status":"phase_3"}]}],"pipeline":[{"name":"Lucanix™","genericName":"Lucanix™","slug":"lucanix","phase":"phase_3","mechanism":"Lucanix is a dendritic cell-based cancer vaccine that activates the immune system to recognize and attack tumor cells expressing PRAME antigen.","indications":["Melanoma (adjuvant setting)","Non-small cell lung cancer"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxQd3dzd2N2XzVlNUJXeF80cll6ZTY0YTFFYzY3cWQ5cXc1Vm1sdTNIYVlsZDBrejhvOHJ4WjFqOGJhWEVtbWRrVFgzYzRDUXVLelJSWHBvQXlpMThJOHlRNlJUMUlMcFNtbUN2N0pMd21MUFJPbDMzcXN6ejQtSUlCekE0NmVjb0w0WGg5ejN3?oc=5","date":"2010-10-01","type":"pipeline","source":"Oneindia","summary":"Dole pineapple heir sued for sexual harassment - Oneindia","headline":"Dole pineapple heir sued for sexual harassment","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}